Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to:


Good News Update
Week of November 9, 2015
David Pollock, PhD
Rationale for ETRA Therapy in Hypertension and Renal Disease

Medical Grand Rounds Calendar

RSCH Singh
EOM foster
SAV Tolwani FPTW